a b c d e f g h i j k l m n o p q r s t u v w x y z #

Plasma Products Lot Release Certificates

 

Albutein 5%, Albumin (Human)-250 mL B3ACB01382

  • Date of Issuance: 27-Dec-17

Albutein 5%, Albumin (Human)-250 mL E3NA6AM001

  • Date of Issuance: 6-Jun-16

Albutein 5%, Albumin (Human)-250 mL T4NA6QT004

  • Date of Issuance: 25-Oct-2016

ALBUTEIN 5%,ALBUMIN (HUMAN)-250ML A1ACC00422

  • Date of Issuance: 19-Jul-18

ALBUTEIN 5%,ALBUMIN (HUMAN)-250ML A4ACC00372

  • Date of Issuance: 18-Jul-18

Alphanate 250 IU Injection A1NAB00102

  • Date of Issuance: 27-Dec-17

Alphanate 250 IU Injection A1NAA00022

  • Date of Issuance: 04-May-17

Alphanate 250 IU Injection A1NAB00022

  • Date of Issuance: 28-Aug-17

Alphanate 250 IU Injection A1NAB00152

  • Date of Issuance: 16-Jan-18

Alphanate 250 IU Injection A1NAB00172

  • Date of Issuance: 3-May-18

Alphanate 250 IU Injection A2NAB00042

  • Date of Issuance: 28-Aug-17

Alphanate 250 IU Injection A2NAB00052

  • Date of Issuance: 2-Oct-17

Alphanate 250 IU Injection A2NAB00112

  • Date of Issuance: 09-Feb-18

Alphanate 250 IU Injection A2NAB00122

  • Date of Issuance: 16-Jan-18

Alphanate 250 IU Injection A2NAB00132

  • Date of Issuance: 7-Nov-17
<<  1 2 3 [45 6 7 8  >>  

National Pharmaceutical Regulatory Agency (NPRA)
Lot 36, Jalan Universiti, 46200 Petaling Jaya, Selangor, Malaysia.
  • Email: npra@npra.gov.my
  • Phone: +603-7883 5400
  • Fax: +603-7956 2924, +603-7956 7075

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

Newsletter Subsription

Site Last Modified

  • Last Modified: Monday 10 December 2018, 14:32:16.
© Copyright 2018 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA